These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 25124149)
1. Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer. Kim MK; Jung SB; Kim JS; Roh MS; Lee JH; Lee EH; Lee HW Virchows Arch; 2014 Oct; 465(4):463-71. PubMed ID: 25124149 [TBL] [Abstract][Full Text] [Related]
2. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Liu XG; Zhu WY; Huang YY; Ma LN; Zhou SQ; Wang YK; Zeng F; Zhou JH; Zhang YK Med Oncol; 2012 Jun; 29(2):618-26. PubMed ID: 21516486 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer. Zhong KZ; Chen WW; Hu XY; Jiang AL; Zhao J Int J Clin Exp Pathol; 2014; 7(7):4545-51. PubMed ID: 25120851 [TBL] [Abstract][Full Text] [Related]
4. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients. Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406 [TBL] [Abstract][Full Text] [Related]
5. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival. Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer. Chen SW; Wang TB; Tian YH; Zheng YG Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival. Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777 [TBL] [Abstract][Full Text] [Related]
8. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients. Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752 [TBL] [Abstract][Full Text] [Related]
9. Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran. Nourmohammadi B; Tafsiri E; Rahimi A; Nourmohammadi Z; Daneshvar Kakhaki A; Cho W; Karimipoor M Asian Pac J Cancer Prev; 2019 Jun; 20(6):1633-1639. PubMed ID: 31244281 [TBL] [Abstract][Full Text] [Related]
10. miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma. Tejero R; Navarro A; Campayo M; Viñolas N; Marrades RM; Cordeiro A; Ruíz-Martínez M; Santasusagna S; Molins L; Ramirez J; Monzó M PLoS One; 2014; 9(7):e101899. PubMed ID: 25003366 [TBL] [Abstract][Full Text] [Related]
11. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance. Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608 [TBL] [Abstract][Full Text] [Related]
12. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096 [TBL] [Abstract][Full Text] [Related]
13. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
14. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
15. Expression analysis of three miRNAs, miR-26a, miR-29b and miR-519d, in relation to MMP-2 expression level in non-small cell lung cancer patients: a pilot study. Pastuszak-Lewandoska D; Kordiak J; Czarnecka KH; Migdalska-Sęk M; Nawrot E; Domańska-Senderowska D; Kiszałkiewicz JM; Antczak A; Górski P; Brzeziańska-Lasota E Med Oncol; 2016 Aug; 33(8):96. PubMed ID: 27447710 [TBL] [Abstract][Full Text] [Related]
16. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer. Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J; Liu H; Wang H; Sun Y Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [TBL] [Abstract][Full Text] [Related]
18. The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases. Goto A; Tanaka M; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Kuriyama S; Konno H; Imai K; Saito H; Minamiya Y; Maeda D PLoS One; 2017; 12(7):e0181270. PubMed ID: 28704499 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer. Yin QW; Sun XF; Yang GT; Li XB; Wu MS; Zhao J Int J Clin Exp Pathol; 2015; 8(1):842-6. PubMed ID: 25755784 [TBL] [Abstract][Full Text] [Related]
20. MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance. Luo L; Zhang T; Liu H; Lv T; Yuan D; Yao Y; Lv Y; Song Y Med Oncol; 2012 Sep; 29(3):1681-6. PubMed ID: 21993632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]